Showing results (371-380 of 1,586) with videos related to

Sort By:
Pageof 159
Asia-Pacific Journal of Clinical Oncology|August 14, 2026
Consolidative Radiotherapy After Gemcitabine-Platinum Chemotherapy in De Novo Metastatic Nasopharyngeal Carcinoma: Impact of Chemotherapy Backbone and Prognostic Factors on SurvivalJoyce L Y Wan, James C H Chow
Asia-Pacific Journal of Clinical Oncology|August 22, 2026
Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in AustraliaEvon Jude, Elizabeth Liow, Jeremy Shapiro, et al.
Asia-Pacific Journal of Clinical Oncology|August 27, 2026
Advancing Homologous Recombination Repair Mutation Testing in Prostate Cancer in Australia: Shifting the Focus to Hormone Sensitive Prostate CancerArun A Azad, Declan G Murphy, Edmond M Kwan, et al.
Asia-Pacific Journal of Clinical Oncology|September 7, 2026
Disparities in the Burden of Prostate Cancer and Its Trends in the Western Pacific Region, 1990-2021Lei Wu, Shijia Yang, Guohong Zhu, et al.
Asia-Pacific Journal of Clinical Oncology|September 28, 2026
NRF2-Regulated Ferroptosis in Breast Cancer: Mechanisms, Resistance, and Therapeutic OpportunitiesSuleiman Ibrahim Mohammad, Asokan Vasudevan, Samreet Raizal Rodrigues, et al.
Asia-Pacific Journal of Clinical Oncology|October 7, 2026
The Impact of Centralized Trophoblastic Care on Patients With Gestational Trophoblastic Neoplasia in a Statewide ServiceChloe Ayres, Evelyn Werner, Vivienne Mallen, et al.
Asia-Pacific Journal of Clinical Oncology|October 10, 2026
Application of Multimodal Respiratory Training Combined With Resistance Exercise in Promoting Postoperative Recovery After Thoracoscopic Lung Cancer ResectionJuan Wu, Juan Liu, Bingqing Luo, et al.
Asia-Pacific Journal of Clinical Oncology|October 16, 2026
Efficacy and Safety of CSF1R Inhibitors for Recurrent or Unresectable Tenosynovial Giant Cell Tumor: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled TrialsMehmood Ahmad, Kanza Farhan, Anwar Ali Khan, et al.
Asia-Pacific Journal of Clinical Oncology|October 15, 2026
Selective Serotonin Receptor (5-HT3) Antagonist Prescribing in Cancer Inpatients: A Retrospective Clinical AuditHenshaw Corey, Matthew Gray, Kim Tam Bui, et al.
Asia-Pacific Journal of Clinical Oncology|October 22, 2026
Hyaluronan-Mediated Motility Receptor Potentiates Colorectal Carcinoma Progression Through PI3K/AKT/mTOR Pathway ModulationCheng Shi, Yu Chen, Xinyu Hu, et al.
Pageof 159